Pharma industry’s deal value decreases by 76.8 per cent in April 2022
The industry reported 113 Venture Capital (VC) deals worth $2.6 billion in April 2022, compared to the last 12-month average…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma deals
Eris enters dermatology therapy, acquires Oaknet Healthcare for Rs 6,500 million
The deal will be financed by Rs 3,000 million of internal accruals and Rs 3,500 million of borrowings
Lupin and Yabao announce strategic partnership in China
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and…
Akums acquires Ankur Drugs and Pharma’s HP plant to boost production capacities
With this acquisition, Akums will boost its production capacities for general oral tablets and oral liquids
Germany agrees deal with CureVac, GSK for mRNA vaccines until 2029
The five-year contract allows for production of up to 80 million doses at short notice until 2029, CureVac said, adding that those…
Lupin completes acquisition of brands from Anglo-French Drugs and Industries
The acquisition of the Anglo-French Drugs and Industries' brands takes Lupin further in shaping its portfolio to emerge as a…
Lupin inks licensing pact with Alvion to market drugs in Southeast Asia
The company said it is committed to provide affordable treatment options to healthcare providers and patients
Pharma deals value decreases by 74.5 per cent in March 2022
The industry reported 163 Venture Capital (VC) deals worth $3.1 billion in March 2022, compared to the last 12-month average…
Zeon Lifesciences signs MoU with Delhi Pharma Sciences and Research University
The MoU aims to accelerate the development of new breakthroughs in the fields of nutraceuticals, phytopharmaceuticals and Ayurveda
Intas and Axantia sign licence and supply agreement for Ranibizumab biosimilar in Middle East
Under the terms of this agreement, Axantia will register, hold the marketing authorisation and commercialise Ranibizumab in…